Blood Test for White Blood Cell Aging Linked to Emotional Symptoms of Depression
Similar Articles
New Study Identifies Distinct Brain Cell Changes in Depression
Elevated Immune Cell Ratio Linked to Higher Dementia Risk in Large Study
Study Links Internalized Stress to Memory Decline in Older Chinese Americans
Harvard Researchers Identify Gut Bacteria Molecule That May Trigger Depression
Anti-Amyloid Drugs Show Limited Benefit for Early Alzheimer's, Carry Side Effects
New research suggests a blood test that measures aging in a specific type of white blood cell may help identify the emotional and cognitive symptoms of depression. The study found this biological marker was associated with feelings like hopelessness and anhedonia in women, regardless of HIV status. This points toward a potential future tool for more objective detection of depression, which currently relies on patient-reported symptoms.
Facts First
- Aging in monocytes, a type of white blood cell, is linked to non-somatic depression symptoms like anhedonia and hopelessness.
- The study involved 440 women, including 261 living with HIV and 179 without.
- The broader epigenetic clock measuring multiple cell types showed no link to depression symptoms.
- Current depression diagnosis lacks an objective biological test and is based on patient-reported symptoms.
- Depression affects nearly one in five U.S. adults and can interfere with medical care adherence.
What Happened
Researchers analyzed blood samples from 440 women to estimate biological age. One clock focused specifically on monocytes found that accelerated aging in these monocytes was strongly associated with emotional and cognitive symptoms of depression, in both women with and without HIV. A broader epigenetic clock measuring multiple cell types did not show this association. Depression symptoms were assessed using a standard 20-item questionnaire.
Why this Matters to You
If you or someone you know has sought help for depression, you may be familiar with the subjective nature of diagnosis, which relies on describing symptoms. This research represents a step toward a future where a blood test could provide an objective biological marker for depression, potentially aiding in earlier or more precise identification of the condition. For the nearly one in five U.S. adults affected by depression, such a tool could one day complement current diagnostic methods.
What's Next
The study's authors have identified a promising biological link between immune system aging and mood disorders. Further research is needed to validate these findings in larger and more diverse populations. If confirmed, this could guide the development of new clinical tests and deepen the understanding of the biological mechanisms linking immune system aging and mood disorders.